Search research articles
Contact Us
Filters
Showing results (101-110 of 122) with videos related to
Page
of 13
Sort By:
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
July 20, 2020
Radiation Oncology Fellowship: a Value-Based Assessment Among Graduates of a Mature Program
Emma Ito, Fabio Y Moraes, Matthew Ramotar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 6, 2021
Elective nodal ultra hypofractionated radiation for prostate cancer: Safety and efficacy from four prospective clinical trials
Rachel M Glicksman, Stanley K Liu, Patrick Cheung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 12, 2020
Single-fraction HDR brachytherapy as monotherapy in low and intermediate risk prostate cancer: Outcomes from two clinical trials with and without an MRI-guided boost
Yasir Alayed, Andrew Loblaw, Merrylee McGuffin, et al.
Brachytherapy
|
July 24, 2025
High-dose-rate (HDR) brachytherapy boost in combination with external beam radiotherapy for localized prostate cancer: An evidence-based consensus statement
Sagar A Patel, Marisa Kollmeier, Juanita Crook, et al.
Clinical and Translational Radiation Oncology
|
November 29, 2021
Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI
Wei Liu, Hatim Fakir, Gurpreet Randhawa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 13, 2022
Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?
Rohann J M Correa, Gerard Morton, Hans T Chung, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 13, 2018
A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy (NRG Oncology/RTOG-0526)
Juanita M Crook, Peixin Zhang, Thomas M Pisansky, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 7, 2023
To Boost or Not to Boost: Pooled Analyses From 2-Fraction SABR Trials for Localized Prostate Cancer
Wee Loon Ong, Patrick Cheung, Hans Chung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 24, 2023
Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer
Wee Loon Ong, Melanie Davidson, Patrick Cheung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 8, 2023
Two-fraction stereotactic ablative radiotherapy with simultaneous boost to MRI-defined dominant intra-prostatic lesion - Results from the 2SMART phase 2 trial
Wee Loon Ong, Patrick Cheung, Hans Chung, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 122) with videos related to
Sort By:
Page
of 13
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
July 20, 2020
Radiation Oncology Fellowship: a Value-Based Assessment Among Graduates of a Mature Program
Emma Ito, Fabio Y Moraes, Matthew Ramotar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 6, 2021
Elective nodal ultra hypofractionated radiation for prostate cancer: Safety and efficacy from four prospective clinical trials
Rachel M Glicksman, Stanley K Liu, Patrick Cheung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 12, 2020
Single-fraction HDR brachytherapy as monotherapy in low and intermediate risk prostate cancer: Outcomes from two clinical trials with and without an MRI-guided boost
Yasir Alayed, Andrew Loblaw, Merrylee McGuffin, et al.
Brachytherapy
|
July 24, 2025
High-dose-rate (HDR) brachytherapy boost in combination with external beam radiotherapy for localized prostate cancer: An evidence-based consensus statement
Sagar A Patel, Marisa Kollmeier, Juanita Crook, et al.
Clinical and Translational Radiation Oncology
|
November 29, 2021
Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI
Wei Liu, Hatim Fakir, Gurpreet Randhawa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 13, 2022
Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?
Rohann J M Correa, Gerard Morton, Hans T Chung, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 13, 2018
A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy (NRG Oncology/RTOG-0526)
Juanita M Crook, Peixin Zhang, Thomas M Pisansky, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 7, 2023
To Boost or Not to Boost: Pooled Analyses From 2-Fraction SABR Trials for Localized Prostate Cancer
Wee Loon Ong, Patrick Cheung, Hans Chung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 24, 2023
Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer
Wee Loon Ong, Melanie Davidson, Patrick Cheung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 8, 2023
Two-fraction stereotactic ablative radiotherapy with simultaneous boost to MRI-defined dominant intra-prostatic lesion - Results from the 2SMART phase 2 trial
Wee Loon Ong, Patrick Cheung, Hans Chung, et al.
Page
of 13